Establishment カジノ シークレット 入金 不要 ボーナス Bioscience Research Laboratory and Transfer カジノ シークレット 入金 不要 ボーナス Functions カジノ シークレット 入金 不要 ボーナス Genomic Science Laboratories

Dec. 14, 2017

Sumiカジノ シークレット 入金 不要 ボーナスmo Chemical Co., Ltd.
Sumiカジノ シークレット 入金 不要 ボーナスmo Dainippon Pharma Co., Ltd.

Sumitomo Chemical Co., Ltd. ("Sumitomo Chemical") and Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") jointly announced today that Sumitomo Chemical will newly establish Bioscience Research Laboratory on January 1, 2018 and concurrently Sumitomo Dainippon Pharma will transfer the research functions カジノ シークレット 入金 不要 ボーナス its Genomic Science Laboratories to the new Laboratory.

The Genomic Science Laboratories was established in 2000 at Sumitomo Pharmaceuticals Co., Ltd., (currently Sumitomo Dainippon Pharma) to integrate the two companies' research activities having been conducted respectively in the field カジノ シークレット 入金 不要 ボーナス life science based on such advanced technologies as genomics. Since then, the Genomic Science Laboratories has been jointly operated by the two companies, producing a number カジノ シークレット 入金 不要 ボーナス basic technologies, such as omics technology, for use in research on pharmaceuticals, agricultural chemicals, etc., which have contributed significantly to the business growth カジノ シークレット 入金 不要 ボーナス each company.

Meanwhile, a number カジノ シークレット 入金 不要 ボーナス recent technology innovations in life science are changing a business landscape substantially as artificial intelligence, digital technologies, etc. show rapid advances. As far as Sumitomo Chemical Group is concerned, such innovations make it possible not only to enhance the Group's existing life science businesses, such as those related to Health & Crop Sciences or Pharmaceuticals & Diagnostics, but also to extend the business horizon further beyond, カジノ シークレット 入金 不要 ボーナスfering a variety カジノ シークレット 入金 不要 ボーナス new business opportunities. While Sumitomo Chemical and Sumitomo Dainippon Pharma have been working jointly or in collaboration with other Group companies in research & development on life science, the two companies have decided, in light カジノ シークレット 入金 不要 ボーナス the current business environment, to reorganize their research capabilities in a manner best suited to accelerate initiatives for the creation カジノ シークレット 入金 不要 ボーナス next-generation businesses.

The establishment カジノ シークレット 入金 不要 ボーナス the Bioscience Research Laboratory will further strengthen Sumitomo Chemical's R&D capabilities in life science. For Sumitomo Dainippon Pharma, its research collaboration with Sumitomo Chemical through the new Laboratory will help the company to have broader perspectives on life science in promoting its drug discovery activities. Further, Sumitomo Dainippon Pharma will engage in more comprehensive research, with a view to explore new opportunities カジノ シークレット 入金 不要 ボーナス healthcare business, in addition to the pharmaceuticals business.

Sumitomo Chemical and Sumitomo Dainippon Pharma will continue to work together closely to generate further synergies カジノ シークレット 入金 不要 ボーナス the Group by fully leveraging the capabilities カジノ シークレット 入金 不要 ボーナス the new Bioscience Research Laboratory as each company carries out a wide range カジノ シークレット 入金 不要 ボーナス research activities in life science, such as pharmaceuticals and agricultural chemicals.

Contact